Laboratory testing is more useful when you know why it is ordered and who will explain the result. A low advertised panel price or a long list of biomarkers cannot establish the quality of testosterone care on its own. This shortlist looks at the questions behind providers’ published testing arrangements.
CoreAge’s product and laboratory descriptions were refreshed September 27, 2026; other entries retain their September 22 research date. First placement is publisher-selected promotion. The page mentions testing but still displays Coming soon, and no diagnostic performance has been independently measured.
KEEP IN MIND
The useful bits.
- CoreAge has disclosed promotional first placement; its injectable listing currently says Coming soon.
- Compare diagnostic confirmation, result explanations, outside-record rules, and follow-up charges.
- Thrivelab’s baseline-testing language needs direct clarification against male TRT guidance.
The comparison list
Number 1 is publisher-selected promotion. These positions do not measure clinical outcomes.
PROMOTIONAL FIRST PLACEMENT
CoreAge Rx
Publisher-selected promotion. Injectable TRT page found; Coming soon still displayed. Confirm opening, full costs, and pharmacy.
Advertised from $129/month; Coming soon
PROVIDER TO COMPARE
Defy Medical
Published initial records and continuing-care requirements; obtain an individualized testing plan.
Testing and consultations purchased as needed
PROVIDER TO COMPARE
TRT Nation
Outside results may be accepted conditionally; separate laboratory charges matter.
TRT labs listed at $129
PROVIDER TO COMPARE
Henry Meds
Testing is described within the bundle; clarify what extra assessment could require.
Published bundled offer; eligibility limits apply
PROVIDER TO COMPARE
Hone Health
Testing and consultation scope differ by membership.
Membership plus medication
PROVIDER TO COMPARE
Thrivelab
Clarify the baseline-testing statement before treating this as an appropriate diagnostic pathway.
Testing and other charges require a personal quote
What a laboratory comparison should establish
Ask how testing confirms the diagnosis, investigates the cause, and supports continuing care. The Endocrine Society recommends symptoms or signs together with consistently low testosterone and repeat morning fasting confirmation. An advertised testing package needs to be understood within that clinical process.
Our testing guide for men over 50 explains the questions to bring. Ask who orders the tests, how to prepare, when results will be discussed, and what happens if further assessment is needed. Those answers cannot be inferred solely from the number of tests in a package.
Sources: Endocrine Society: testosterone therapy clinical guidance
CoreAge Rx: confirm the collection arrangement and panel
CoreAge’s TRT page describes blood tests followed by a virtual consultation. It mentions a home draw or an in-person visit in one section and Quest locations in its FAQ. Ask which arrangement is available for your address and whether the advertised starting amount includes the required panel.
The updated review also identifies questions about repeat confirmation and ongoing testing. Those requirements need a clinician’s plan. A laboratory-access description does not establish the quality of interpretation, automatic acceptance of old reports, or a confirmed launch date for care.
Sources: CoreAge Rx: injectable TRT product page and Coming soon status · CoreAge Rx: general service, billing, and pharmacy FAQ · CoreAge Rx: refund, subscription, and shipping policy
Defy and TRT Nation: ask about existing records
Defy lists a specified men’s panel and a recent physical among its entry requirements, then publishes a general follow-up process. TRT Nation describes conditional acceptance of suitable outside results and lists a separate TRT laboratory charge. These differences can affect both the work required to begin and the starting bill.
Read the Defy versus TRT Nation comparison before treating a previous panel as automatically acceptable. Ask which missing information would trigger more testing and how the clinician will decide. Administrative acceptance and clinical sufficiency are related questions, but they are not identical.
Sources: Defy Medical: initial and continuing TRT patient requirements · TRT Nation: laboratory costs, state access, and clinical process
Henry and Hone: included testing still needs context
Henry advertises laboratory work within its treatment bundle. Hone describes testing features that vary by membership, with medication priced separately. Ask which tests and visits apply to the actual plan and whether additional evaluation can create charges beyond the advertised scope.
Our Henry review and Hone review separate those commercial descriptions. Included testing is not proof of a complete diagnosis, and a more frequent advertised interval is not automatically better for every patient. The clinician should explain the purpose and timing of the individual plan.
Sources: Henry Meds: TRT plans, costs, eligibility, and cancellation FAQ · Hone Health: Basic and Premium memberships and starting assessment
Thrivelab requires a specific baseline-testing question
Thrivelab’s FAQ describes potentially beginning BHRT or TRT without baseline labs. That differs from the male hypogonadism confirmation process described in Endocrine Society guidance and needs clarification before testosterone prescribing. We do not endorse skipping diagnostic confirmation or infer the details of every patient’s consultation from the website.
The Thrivelab review discusses this limitation directly. General hormone-balancing or menopausal-care language does not answer the male TRT question. Ask the clinician how symptoms, repeat measurements, and the cause would be assessed before treating the service as comparable on testing.
Sources: Thrivelab: men’s program, price components, and testing FAQ · Endocrine Society: testosterone therapy clinical guidance
Plan for explanations as well as blood draws
Ask how results are communicated, who responds to questions, and how monitoring changes if the prescription or health circumstances change. Blood pressure, blood counts, symptoms, adverse effects, and ongoing benefit all need an appropriate clinical plan. A portal full of numbers is not a substitute for understanding the next step.
If you are changing services, use the handoff guide to organize records. The aim of this shortlist is to make responsibilities visible, not to direct you to the biggest panel or promise that any listed provider will diagnose, prescribe, or monitor appropriately for every reader.
Already have results from another clinician? Compare the outside-lab policies and questions before paying for another panel.
Sources: Endocrine Society: testosterone therapy clinical guidance · FDA: 2025 testosterone labeling and blood pressure changes
Sources you can check
Provider pages describe commercial offers. Medical references provide context. Source review: September 22, 2026. CoreAge details rechecked September 27, 2026. Prices and availability can change.
- Endocrine Society: testosterone therapy clinical guidance
- CoreAge Rx: injectable TRT product page and Coming soon status
- CoreAge Rx: general service, billing, and pharmacy FAQ
- CoreAge Rx: refund, subscription, and shipping policy
- Defy Medical: initial and continuing TRT patient requirements
- TRT Nation: laboratory costs, state access, and clinical process
- Henry Meds: TRT plans, costs, eligibility, and cancellation FAQ
- Hone Health: Basic and Premium memberships and starting assessment
- Thrivelab: men’s program, price components, and testing FAQ
- FDA: 2025 testosterone labeling and blood pressure changes
A FREE TAKE-HOME FROM THE DESK
Before you commit,
put it on paper.
Get the TRT Decision Kit: a first-year cost worksheet, 12 questions to ask a clinic, and a checklist for reading the fine print.
Free for every subscriber. Educational resources, with five short daily emails to help you use them. No purchase needed.
See what’s in the kit ↗Form not loading? Open the signup form. Privacy & email preferences.
Educational information for adults, not a diagnosis or treatment plan. Discuss symptoms and treatment decisions with a licensed clinician. Do not change a prescription based on this article.